AstraZeneca Ups Core EPS Guidance Despite Profit Miss
Wall Street Journal
AstraZeneca raised its full-year guidance for core earnings per share and total revenue excluding Covid-19 medicines despite a lower third-quarter profit that missed forecasts.
https://www.wsj.com/articles/astrazeneca-raises-core-eps-guidance-despite-profit-miss-bea5619c